High-Level Expression of Alkaline Phosphatase by Adeno-Associated Virus Vector Ameliorates Pathological Bone Structure in a Hypophosphatasia Mouse Model
Open Access
- 19 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Calcified Tissue International
- Vol. 106 (6), 665-677
- https://doi.org/10.1007/s00223-020-00676-5
Abstract
Hypophosphatasia (HPP) is a systemic skeletal disease caused by mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNALP). We recently reported that survival of HPP model mice can be prolonged using an adeno-associated virus (AAV) vector expressing bone-targeted TNALP with deca-aspartate at the C terminus (TNALP-D10); however, abnormal bone structure and hypomineralization remained in the treated mice. Here, to develop a more effective and clinically applicable approach, we assessed whether transfection with TNALP-D10 expressing virus vector at a higher dose than previously used would ameliorate bone structure defects. We constructed a self-complementary AAV8 vector expressing TNALP driven by the chicken beta-actin (CBA) promoter (scAAV8-CB-TNALP-D10). The vector was injected into both quadriceps femoris muscles of newborn HPP mice at a dose of 4.5 × 1012 vector genome (v.g.)/body, resulting in 20 U/mL of serum ALP activity. The 4.5 × 1012 v.g./body-treated HPP mice grew normally and displayed improved bone structure at the knee joints in X-ray images. Micro-CT analysis showed normal trabecular bone structure and mineralization. The mechanical properties of the femur were also recovered. Histological analysis of the femurs demonstrated that ALP replacement levels were sufficient to promote normal, growth plate cartilage arrangement. These results suggest that AAV vector-mediated high-dose TNALP-D10 therapy is a promising option for improving the quality of life (QOL) of patients with the infantile form of HPP.Keywords
This publication has 46 references indexed in Scilit:
- Enzyme replacement therapy on hypophosphatasia mouse modelJournal of Inherited Metabolic Disease, 2013
- Successful Gene Therapy in Utero for Lethal Murine HypophosphatasiaHuman Gene Therapy, 2012
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BThe New England Journal of Medicine, 2011
- Rescue of Severe Infantile Hypophosphatasia Mice by AAV-Mediated Sustained Expression of Soluble Alkaline PhosphataseHuman Gene Therapy, 2011
- Hypophosphatasia: Nonlethal disease despite skeletal presentation in utero (17 new cases and literature review)Journal of Bone and Mineral Research, 2011
- Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α2/δ-1 subunits of the voltage-gated calcium channelsNeuroscience, 2011
- Prolonged survival and phenotypic correction of Akp2−/− hypophosphatasia mice by lentiviral gene therapyJournal of Bone and Mineral Research, 2010
- Enzyme Replacement Therapy for Murine HypophosphatasiaJournal of Bone and Mineral Research, 2008
- HypophosphatasiaOrphanet Journal of Rare Diseases, 2007
- Infantile hypophosphatasia: Enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone diseaseThe Journal of Pediatrics, 1982